Filing Details

Accession Number:
0001159036-14-000062
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-16 16:26:04
Reporting Period:
2014-05-15
Filing Date:
2014-05-16
Accepted Time:
2014-05-16 16:26:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1159036 Halozyme Therapeutics Inc HALO Biological Products, (No Disgnostic Substances) (2836) 880488686
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1078452 Robert Engler C/O Halozyme Therapeutics, Inc.
11388 Sorrento Valley Road
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-15 150,000 $4.10 359,876 No 4 M Direct
Common Stock Disposition 2014-05-15 126,700 $7.56 233,176 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Common Stock (NSO) Disposition 2014-05-15 150,000 $4.10 150,000 $4.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-05-21 2014-05-21 No 4 M Direct